Advertisement
Screener

Royalty Pharma plc (RPRX) Pre-Tax Margin

Royalty Pharma plc (RPRX) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin 12.09%.
  • 2026-03-31: Pre-Tax Margin 74.26%.
  • 2025-12-31: Pre-Tax Margin 57.22%.
  • 2025-09-30: Pre-Tax Margin 72.91%.

Complete source-backed pre-tax margin history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-3012.09%
2026-03-3174.26%
2025-12-3157.22%
2025-09-3072.91%
2025-06-3016.01%
2025-03-3176.45%
2024-12-3156.32%
2024-09-30142.80%
2024-06-3036.18%
2024-03-31-0.75%
2023-12-31120.39%
2023-09-3022.76%
2023-06-3065.28%
2023-03-3174.43%
2022-12-31-107.83%
2022-09-3038.44%
2022-06-3091.72%
2022-03-3122.79%
2021-12-319.32%
2021-09-3037.86%
2021-06-30145.37%
2021-03-3127.74%
2020-12-3164.08%
2020-09-30115.95%
2020-06-30117.82%
2020-03-3121.78%
2019-12-31316.19%
2019-09-3094.78%
2019-06-3039.07%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-3155.68%
2024-12-3158.79%
2023-12-3172.20%
2022-12-3110.28%
2021-12-3154.21%
2020-12-3180.19%
2019-12-31135.67%
2018-12-3184.57%

Similar stocks

Stock NameCountryMarket CapPE Ratio
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Zoetis Inc. (ZTS)United States$29.045B11.38
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80